{"lastClose": 4.650000095367432, "len": 976, "date": "2023-02-16", "alpha_1": -0.7582415722335327, "beta_1": 0.9073412200300279, "drawup_1": 0.7155424508464454, "natr_1": 18.625434270209603, "sup_1": -1.0236559080242325, "res_1": 0.7612902645817229, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 47.701151315248595, "adx_1": 37.35480124163162, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.6472247011267759, "stratHoldAlpha_1": 250.46066242750533, "stratHoldDrawdown_1": -0.732492433009918, "alpha_3mo": -0.23978843641217296, "beta_3mo": 1.5352172710332475, "drawup_3mo": 0.20805376931257258, "natr_3mo": 18.625434270209603, "sup_3mo": -0.09906809613898296, "res_3mo": 0.031111111566869437, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 35.135123815034746, "adx_3mo": 30.224046357410298, "drawdown_3mo": -0.20178573815798317, "stratHoldSharpe_3mo": -0.3417445693823842, "stratHoldAlpha_3mo": 250.8328218292151, "stratHoldDrawdown_3mo": -0.1835408977710431, "Market Cap": 379617795, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Country": "United States", "Sector": "Health Care", "IPO Year": 2019.0, "Name": "NGM Biopharmaceuticals Inc.", "alpha%_1": 0.014968868171244529, "beta%_1": 0.4401900750634975, "drawup%_1": 0.6652256976365025, "natr%_1": 0.9999999998617554, "drawdown%_1": 0.016150159074509077, "stratHoldSharpe%_1": 0.14655564938859572, "stratHoldAlpha%_1": 0.013242097684368941, "stratHoldDrawdown%_1": 0.016967514271676445, "alpha%_3mo": 0.1879951963948947, "beta%_3mo": 0.850512442669807, "drawup%_3mo": 0.39182641573293675, "natr%_3mo": 0.999999999701961, "drawdown%_3mo": 0.23569718387844085, "stratHoldSharpe%_3mo": 0.19193150926271219, "stratHoldAlpha%_3mo": 0.18755685836415797, "stratHoldDrawdown%_3mo": 0.2336876792149587}